Terms: = Leukemia AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Treatment
176 results:
1. Testing an Intervention to Improve Health Care Worker Well-Being During the COVID-19 Pandemic: A Cluster Randomized Clinical Trial.
Meredith LS; Ahluwalia S; Chen PG; Dong L; Farmer CM; Bouskill KE; Dalton S; Qureshi N; Blagg T; Timmins G; Schulson LB; Huilgol SS; Han B; Williamson S; Watson P; Schnurr PP; Martineau M; Davis K; Cassells A; Tobin JN; Gidengil C
JAMA Netw Open; 2024 Apr; 7(4):e244192. PubMed ID: 38687482
[TBL] [Abstract] [Full Text] [Related]
2. Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study.
Zhao L; Yang J; Chen M; Xiang X; Ma H; Niu T; Gong Y; Chen X; Liu J; Wu Y
Ann Hematol; 2024 Apr; 103(4):1197-1209. PubMed ID: 38329487
[TBL] [Abstract] [Full Text] [Related]
3. Iron Overload in Children With leukemia; Identification of a Cutoff Value for Serum Ferritin Level.
Zekavat OR; Fallah Tafti F; Bordbar M; Parand S; Haghpanah S
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e137-e142. PubMed ID: 38132565
[TBL] [Abstract] [Full Text] [Related]
4. Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach.
Busch C; Mulholland T; Zagnoni M; Dalby M; Berry C; Wheadon H
Cell Commun Signal; 2023 Nov; 21(1):342. PubMed ID: 38031192
[TBL] [Abstract] [Full Text] [Related]
5. Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001.
Ravandi F; Döhner H; Wei AH; Montesinos P; Pfeilstöcker M; Papayannidis C; Lai Y; Wang K; See WL; de Menezes DL; Petrlik E; Prebet T; Roboz GJ
Br J Haematol; 2024 Mar; 204(3):877-886. PubMed ID: 37952982
[TBL] [Abstract] [Full Text] [Related]
6. Flow cytometric signature of CD371-positive B-cell acute lymphoblastic leukemia.
Shakah H; Tbakhi A; Khudirat S; Abweh RA; Hasasna N; Alwhaidi A; Khoujah A; Barakat F
J Int Med Res; 2023 Oct; 51(10):3000605231203842. PubMed ID: 37818740
[TBL] [Abstract] [Full Text] [Related]
7. COVID-19 in patients with classic and variant hairy cell leukemia.
Kreitman RJ; Yu T; James L; Feurtado J; Eager H; Ortiz OS; Gould M; Mauter J; Zhou H; Burbelo PD; Cohen JI; Wang HW; Yuan CM; Arons E
Blood Adv; 2023 Dec; 7(23):7161-7168. PubMed ID: 37729613
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy of gilteritinib in comparison with alectinib for the treatment of alk-rearranged non-small cell lung cancer.
Ando C; Ichihara E; Nishi T; Morita A; Hara N; Takada K; Nakasuka T; Watanabe H; Kano H; Nishii K; Makimoto G; Kondo T; Ninomiya K; Fujii M; Kubo T; Ohashi K; Matsuoka KI; Hotta K; Tabata M; Maeda Y; Kiura K
Cancer Sci; 2023 Nov; 114(11):4343-4354. PubMed ID: 37715310
[TBL] [Abstract] [Full Text] [Related]
9. Comparing presentations and outcomes of children with cancer: a study between a lower-middle-income country and a high-income country.
Farrag A; Ghazaly MH; Mohammed K; Volland R; Hero B; Berthold F
BMC Pediatr; 2023 Sep; 23(1):443. PubMed ID: 37670249
[TBL] [Abstract] [Full Text] [Related]
10. Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML).
Pohlmann A; Bentgens E; Schülke C; Kuron D; Reicherts C; Marx J; Angenendt L; Mikesch JH; Lenz G; Stelljes M; Schliemann C
Ann Hematol; 2023 Sep; 102(9):2543-2553. PubMed ID: 37428201
[TBL] [Abstract] [Full Text] [Related]
11. B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic leukemia on Continuous Ibrutinib Therapy.
Woyach JA; Ghia P; Byrd JC; Ahn IE; Moreno C; O'Brien SM; Jones D; Cheung LWK; Chong E; Kwei K; Dean JP; James DF; Wiestner A
Clin Cancer Res; 2023 Aug; 29(16):3065-3073. PubMed ID: 37314786
[TBL] [Abstract] [Full Text] [Related]
12. Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus.
Moosburner M; Alibegovic L; Hasselmann K; Gaiderov A; Hildebrand J; Philippou-Massier J; Blum H; Fischer L; Dreyling M; Silkenstedt E
Hematol Oncol; 2023 Dec; 41(5):858-868. PubMed ID: 37300279
[TBL] [Abstract] [Full Text] [Related]
13. Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.
Sato A; Hatta Y; Imai C; Oshima K; Okamoto Y; Deguchi T; Hashii Y; Fukushima T; Hori T; Kiyokawa N; Kato M; Saito S; Anami K; Sakamoto T; Kosaka Y; Suenobu S; Imamura T; Kada A; Saito AM; Manabe A; Kiyoi H; Matsumura I; Koh K; Watanabe A; Miyazaki Y; Horibe K
Lancet Haematol; 2023 Jun; 10(6):e419-e432. PubMed ID: 37167992
[TBL] [Abstract] [Full Text] [Related]
14. [Efficacy and Safety of Decitabine Combined with Modified EIAG Regimen in the treatment of Patients with Relapsed/Refractory Acute Myeloid leukemia and High-risk Myelodysplastic Syndrome].
Mao JP; Xue LG; Zhu YX; Jia T; Wang Y; Miao L; Wei JF; Zhao LD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):338-343. PubMed ID: 37096503
[TBL] [Abstract] [Full Text] [Related]
15. A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells.
Zhao T; He Q; Xie S; Zhan H; Jiang C; Lin S; Liu F; Wang C; Chen G; Zeng H
Mol Med; 2023 Jan; 29(1):10. PubMed ID: 36658493
[TBL] [Abstract] [Full Text] [Related]
16. Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.
Chiappella A; Dodero A; Evangelista A; Re A; Orsucci L; Usai SV; Castellino C; Stefoni V; Pinto A; Zanni M; Ciancia R; Ghiggi C; Rossi FG; Arcari A; Ilariucci F; Zilioli VR; Flenghi L; Celli M; Volpetti S; Benedetti F; Ballerini F; Musuraca G; Bruna R; Patti C; Leonardi F; Arcaini L; Magagnoli M; Cavallo F; Bermema A; Tucci A; Boccomini C; Ciccone G; Carniti C; Pileri SA; Corradini P
Leukemia; 2023 Feb; 37(2):433-440. PubMed ID: 36653509
[TBL] [Abstract] [Full Text] [Related]
17. From the archives of MD Anderson Cancer Center: Aleukemic T-prolymphocytic leukemia, a rare presentation and review of the literature.
Nahmod KA; Thakral B; Aakash FNU; Iyer SP; Medeiros LJ; Quesada AE
Ann Diagn Pathol; 2023 Feb; 62():152077. PubMed ID: 36549077
[TBL] [Abstract] [Full Text] [Related]
18. Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.
Tam CS; Brown JR; Kahl BS; Ghia P; Giannopoulos K; Jurczak W; Šimkovič M; Shadman M; Österborg A; Laurenti L; Walker P; Opat S; Chan H; Ciepluch H; Greil R; Tani M; Trněný M; Brander DM; Flinn IW; Grosicki S; Verner E; Tedeschi A; Li J; Tian T; Zhou L; Marimpietri C; Paik JC; Cohen A; Huang J; Robak T; Hillmen P
Lancet Oncol; 2022 Aug; 23(8):1031-1043. PubMed ID: 35810754
[TBL] [Abstract] [Full Text] [Related]
19. [Characteristics and prognostic effects of NOTCH1/FBXW7 gene mutations in T-cell acute lymphoblastic leukemia patients].
Wu CY; Li YL; Dong XY; Yang SW; Shang BJ; Zhang L; Cheng W; Zhang L; Zhu ZM
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1910-1917. PubMed ID: 35768390
[No Abstract] [Full Text] [Related]
20. Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML.
Adès L; Girshova L; Doronin VA; Díez-Campelo M; Valcárcel D; Kambhampati S; Viniou NA; Woszczyk D; De Paz Arias R; Symeonidis A; Anagnostopoulos A; Munhoz EC; Platzbecker U; Santini V; Fram RJ; Yuan Y; Friedlander S; Faller DV; Sekeres MA
Blood Adv; 2022 Sep; 6(17):5132-5145. PubMed ID: 35728048
[TBL] [Abstract] [Full Text] [Related]
[Next]